1Serrano M,Hannon GJ,Beach D,et al.A new regulatory motif in cell cycle control causing specific inhibition of cyclinD/CDK4[J].Nature,1993,366(6456):704-707.
2Kamb A,Cruis NA,Weaverfeldhaus J,et al.A cell cycle regulator potentially involved in genesis of many tumor types[J].Science,1994,264(3):436-440.
3Caldas C,Halm SA,Costa D,et al.Frequent somaticmutations and homozygous deletions of the MTS1gene in pancreatic adenocarcinoma[J].Nature Geret,1994,8(1):27-32.
10Lee TL,Leung WK,Chan MW,et al.Detection of gene promoter hypermethylation in the tumor and serum of Patients with gastric carcinoma[J].Clin Cancer Res,2002,8(6):1761-1766.
3Kamb A,Gruis NA,Weaver FJ,et al. A cell cycle regulator potentially involved in genesis of many tumor types[J]. Science,1994,264:436-440.
4Jin X，Cancer Res，1995年，55卷，3250页
5Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet, 1999, 21: 163-167.
6Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res, 1995, 55: 4525-4530.
7Otterson GA, Khleif SN, Chen W, et al. CDNK2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-Aza-2′-deoxycytidine. Oncogene, 1995, 11: 1211-1216.
8Sanchez-Cespedes M, Esteller M, Wu L, et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res, 2000, 60:892-895.
9Heid CA, Stevens J, Livak KJ. Real time quantitative PCR. Genome Res, 1996, 6: 986-994.
10Mizuno S, Chijiwa T, Okamura T, et al. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood, 2001, 97: 1172-1179.
